Loss of speech | Weakness | Loss of sight | At least one symptom | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
N | Per cent* | OR† (95% CI) | N | Per cent* | OR† (95% CI) | N | Per cent* | OR† (95% CI) | N | Per cent* | OR† (95% CI) | |
Gender | ||||||||||||
Male | 119 | 2.5 | 1.0 | 257 | 5.5 | 1.0 | 347 | 7.6 | 1.0 | 598 | 12.8 | 1.0 |
Female | 152 | 2.2 | 0.9 (0.7 to 1.2) | 339 | 4.8 | 0.9 (0.7 to 1.0) | 525 | 7.6 | 1.0 (0.9 to 1.2) | 858 | 12.0 | 1.0 (0.9 to 1.1) |
Age (years) | ||||||||||||
65–74 | 137 | 2.3 | 1.0 | 302 | 5.1 | 1.0 | 480 | 8.1 | 1.0 | 768 | 12.9 | 1.0 |
75–84 | 104 | 2.3 | 0.7 (0.7 to 1.2) | 229 | 5.0 | 0.9 (0.7 to 1.1) | 327 | 7.2 | 0.9 (0.7 to 1.1) | 553 | 12.0 | 0.9 (0.8 to 1.0) |
85+ | 30 | 2.5 | 0.8 (0.5 to 1.3) | 65 | 5.4 | 0.9 (0.6 to 1.2) | 65 | 5.4 | 0.6 (0.5 to 0.8) | 134 | 10.4 | 0.7 (0.6 to 0.9) |
Social class‡ | ||||||||||||
Non-manual | 96 | 5.8 | 1.0 | 63 | 11.0 | 1.0 | 295 | 17.9 | 1.0 | 497 | 10.2 | 1.0 |
Manual | 164 | 7.2 | 1.1 (0.9 to 1.5) | 390 | 17.8 | 1.4 (1.2 to 1.7) | 556 | 25.7 | 1.4 (1.2 to 1.6) | 920 | 14.1 | 1.4 (1.2 to 1.6) |
Comorbidity | ||||||||||||
Angina (n=1538) | 64 | 4.3 | 1.5 (1.0 to 2.2) | 176 | 11.7 | 2.5 (2.0 to 3.2) | 160 | 10.6 | 1.3 (1.0 to 1.6) | 312 | 20.7 | 1.7 (1.4 to 1.9) |
Diabetes (n=672) | 28 | 4.0 | 1.4 (0.9 to 2.2) | 40 | 6.1 | 1.0 (0.7 to 1.4) | 66 | 10.1 | 1.3 (0.9 to 1.7) | 102 | 15.2 | 1.1 (0.9 to 1.4) |
Heart attack (n=1139) | 52 | 4.7 | 1.8 (1.2 to 2.7) | 131 | 10.5 | 1.4 (1.2 to 1.9) | 119 | 11.5 | 1.4 (1.1 to 1.8) | 233 | 12.4 | 1.4 (1.2 to 1.8) |
*Weighted percentages.
†Adjusted for age, sex, social class, cognition and cardiovascular comorbidities.
‡Reference non-manual (I, II and IIIa) compared to manual social class (IIIb, IV and V).
156 participants had missing data on the speech questionnaire, 155 on the weakness and 154 on the sight question.